If you have a family member going through chemotherapy, you'll find it's more common than you'd think to switch drugs once, then twice, and then on to a third. Of course you hope the first drug works well, but among cervical cancers, the adenocarcinoma type tends to respond unevenly to standard chemotherapy, so even the medical team can't promise to "see it through with a single drug." That's exactly why caregivers, gripped by the thought of "if even this drug fails, what's left?", start looking into other hospitals and other trials. That feeling is completely understandable.
The first thing I want to point out is that the kinds of clinical trials being run differ from one hospital to the next. Even among large hospitals, some are very active in trials combining immunotherapy drugs, while others run more trials of targeted therapies or single new agents. Just because Hospital A told you "there's no suitable trial here" does not mean Hospital B has none either. So if you hit a dead end at one place, there's no need to stop there. That said, each trial has strict criteria for who can enroll (eligibility criteria), so qualification depends on things like how far the cancer has invaded the rectum or other organs, and which drugs you've already used and how many times.
Many people ask about timing. To be honest, the moment you start sensing that "the chemo we're on now probably isn't working" is the time to start looking. With trials, you can't just apply and be enrolled right away; tests, paperwork, and review all take time. Yet most trials only allow enrollment "after the most recent treatment has been confirmed to have failed." So the idea is to book a consultation in advance and clear the path, while the actual switch happens only after you've confirmed how the current drug is doing. The key stage is simply finding out in advance, neither too early nor too late.
Some people are also unsure about which department to go to. If the cancer has spread to several places and you're continuing whole-body (systemic) chemotherapy, the medical oncology department (hematology-oncology) takes a broader view of drug selection and connecting you to trials than obstetrics and gynecology does. Even if the initial diagnosis and surgery were done in obstetrics and gynecology, now that drug treatment has become the center of care, it's worth considering a co-consultation with, or a transfer to, medical oncology. When you book an appointment at the hospital you're moving to, mention this point up front and it will be easier for them to direct you to the right department.
And then there's the situation where the patient can't go in person because of difficulty breathing. This is a wall that so many caregivers run into. Whether a caregiver can come alone for a consultation when the patient cannot accompany them depends on each hospital's and department's policy, and for a first visit many places require the patient to come in person. Still, if you bring along medical records in advance, such as past imaging studies (CT image files), the chemotherapy history, and biopsy results, that first consultation becomes far more substantial. When you call to make the appointment, ask point-blank: "the patient has trouble getting around, is a caregiver-only consultation possible?" Sometimes a door opens where you assumed there was none.
What I've written here is just a general outline offered from the sidelines. The right answer differs with each patient's condition, so in the end, checking directly with your attending physician and with the medical oncology department at the hospital you'll be moving to is the most reliable course.
Disclaimer: This article is general information for reference only and is not a substitute for professional medical advice or diagnosis. Treatment decisions must be made in consultation with your attending physician and qualified specialists.